Apple infringed on one of medical technology company Masimo's pulse oximeter patents when it launched Apple Watch models that use light sensors to measure the amount of oxygen in the blood ...

Masimo Corp. Chief Executive Officer Joe Kiani ... had the tool — a gauge of blood oxygen saturation known as a pulse oximeter — which had been a heavily marketed health feature on the ...

Today’s report is the latest episode in a long-running battle between the two companies over whether or not the Apple Watch’s pulse oximeter uses Masimo’s patented tech … Way back in 2013 ...

Masimo, for its part, has declared racial bias a non-issue in its own flagship SET pulse oximeter: Study results (PDF) published this month found no clinically significant difference in the device ...

The latest legal dispute between Apple and pulse oximetry company Masimo today ended in a mistrial, reports Bloomberg. The jury overseeing the case was not able to come to a final decision in its ...

Over the years, he built new and better pulse oximeters, becoming the leader in the tech in the United States. Thanks to Masimo’s pulse oximeters, millions of at-risk people have been able to ...

Late last year, Apple halted sales of its Series 9 and Watch Ultra 2 Apple Watch models over a years-long patent dispute with health technology company Masimo, a maker of pulse oximeters.

Nearly two months ago, the ITC found several Apple Watches infringed on Masimo’s pulse oximeter patents, sparking a review period that would allow Apple to make a licensing deal with Masimo or ...

The global pulse oximeters market reached a value of US$ 2.14 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 3.25 Billion by 2027, exhibiting a CAGR of 7.1% during ...